Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers

Triple-negative breast cancers (TNBCs) often have a high Ki-67 proliferation index and respond favorably to neoadjuvant chemotherapy (NACT) with pathologic complete response (pCR) resulting in ~40% of cases. Nevertheless, morbidity/mortality remain high, mostly due to recurrence in patients with res...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Pooja, Wang, Tiannan, Clark, Beth Z., Yu, Jing, Fine, Jeffrey L., Villatoro, Tatiana M., Carter, Gloria J., Brufsky, Adam M., Gorantla, Vikram C., Huggins-Puhalla, Shannon L., Emens, Leisha A., Basili, Thais, da Silva, Edaise M., Reis-Filho, Jorge S., Bhargava, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021249/
https://www.ncbi.nlm.nih.gov/pubmed/35444182
http://dx.doi.org/10.1038/s41523-022-00415-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021249/
https://www.ncbi.nlm.nih.gov/pubmed/35444182
http://dx.doi.org/10.1038/s41523-022-00415-z

Ejemplares similares